Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.71
0.11 (18.02%)
At close: Jun 30, 2025, 3:59 PM
0.66
-6.61%
After-hours: Jun 30, 2025, 05:45 PM EDT
18.02% (1D)
| Bid | 0.6 |
| Market Cap | 6.72M |
| Revenue (ttm) | 37.99M |
| Net Income (ttm) | -11.53M |
| EPS (ttm) | -0.81 |
| PE Ratio (ttm) | -0.88 |
| Forward PE | -1.07 |
| Analyst | Buy |
| Ask | 0.72 |
| Volume | 1,068,697 |
| Avg. Volume (20D) | 144,664 |
| Open | 0.65 |
| Previous Close | 0.60 |
| Day's Range | 0.59 - 0.76 |
| 52-Week Range | 0.54 - 2.22 |
| Beta | 0.30 |
About BFRI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BFRI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BFRI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Biofrontera Inc. is scheduled to release its earnings on Aug 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-16.5%
Biofrontera shares are trading lower after the com...
Unlock content with
Pro Subscription
5 months ago
+6.31%
Biofrontera shares are trading higher after the company announced the last patient completed the 1 year follow-up of study ALA-BCC-CT013 in December 2024.
1 month ago · accessnewswire.com
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025WOBURN, MA / ACCESS Newswire / May 6, 2025 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological produc...